ProfileGDS4718 / 225467_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 93% 87% 93% 92% 90% 92% 93% 92% 91% 92% 92% 93% 88% 92% 91% 90% 89% 92% 94% 93% 91% 90% 93% 92% 91% 91% 87% 95% 93% 89% 91% 92% 94% 89% 88% 92% 93% 90% 79% 92% 90% 86% 90% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.481295
GSM549102patient 115, normal, homogenized [OPG study]9.8383993
GSM549104patient 119, normal, homogenized [OPG study]8.8024487
GSM549108patient 138, normal, homogenized [OPG study]9.7860593
GSM549119patient 077, normal, homogenized [OPG study]9.5584592
GSM549133patient 032, cancer, homogenized [OPG study]9.3171590
GSM549139patient 042, cancer, homogenized [OPG study]9.5881992
GSM549099patient 107, normal, homogenized [OPG study]9.7005393
GSM549109patient 139, normal, homogenized [OPG study]9.6213492
GSM549110patient 046, normal, homogenized [OPG study]9.3584491
GSM549114patient 063, normal, homogenized [OPG study]9.7406892
GSM549122patient 082, normal, homogenized [OPG study]9.5843892
GSM549134patient 033, cancer, homogenized [OPG study]9.8241193
GSM549136patient 036, cancer, homogenized [OPG study]8.9330388
GSM549140patient 044, cancer, homogenized [OPG study]9.5597992
GSM549111patient 047, normal, homogenized [OPG study]9.4801591
GSM549113patient 057, normal, homogenized [OPG study]9.3359690
GSM549132patient 031, cancer, homogenized [OPG study]9.0687189
GSM549137patient 038, cancer, homogenized [OPG study]9.4356992
GSM549142patient 047, cancer, homogenized [OPG study]9.5267294
GSM549100patient 110, normal, homogenized [OPG study]9.7480393
GSM549107patient 135, normal, homogenized [OPG study]9.4953691
GSM549115patient 068, normal, homogenized [OPG study]9.4726390
GSM549116patient 072, normal, homogenized [OPG study]9.7684893
GSM549120patient 078, normal, homogenized [OPG study]9.6965492
GSM549131patient 030, cancer, homogenized [OPG study]9.5062691
GSM549118patient 074, normal, homogenized [OPG study]9.4806291
GSM549129patient 027, cancer, homogenized [OPG study]8.625887
GSM549123patient 088, normal, homogenized [OPG study]10.24795
GSM549124patient 006, cancer, homogenized [OPG study]9.6291693
GSM549126patient 015, cancer, homogenized [OPG study]8.9092189
GSM549128patient 025, cancer, homogenized [OPG study]9.4287591
GSM549103patient 117, normal, homogenized [OPG study]9.4710692
GSM549117patient 073, normal, homogenized [OPG study]10.099794
GSM549138patient 041, cancer, homogenized [OPG study]9.10289
GSM549141patient 045, cancer, homogenized [OPG study]8.9327688
GSM549130patient 028, cancer, homogenized [OPG study]9.3624292
GSM549101patient 111, normal, homogenized [OPG study]9.6704893
GSM549105patient 128, normal, homogenized [OPG study]9.2312490
GSM549106patient 134, normal, homogenized [OPG study]7.9516779
GSM549112patient 048, normal, homogenized [OPG study]9.6019492
GSM549125patient 011, cancer, homogenized [OPG study]9.1065190
GSM549127patient 024, cancer, homogenized [OPG study]8.5987786
GSM549135patient 035, cancer, homogenized [OPG study]9.1951390